These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25263506)
1. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. Henderson SA; Tetzlaff MT; Pattanaprichakul P; Fox P; Torres-Cabala CA; Bassett RL; Prieto VG; Richards HW; Curry JL J Cutan Pathol; 2014 Nov; 41(11):846-52. PubMed ID: 25263506 [TBL] [Abstract][Full Text] [Related]
2. Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices. Iwasaki T; Matsushita M; Nonaka D; Kato M; Nagata K; Murakami I; Hayashi K Pathol Int; 2015 Aug; 65(8):404-9. PubMed ID: 25982855 [TBL] [Abstract][Full Text] [Related]
3. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. Ladstein RG; Bachmann IM; Straume O; Akslen LA BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247 [TBL] [Abstract][Full Text] [Related]
4. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III. Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054 [TBL] [Abstract][Full Text] [Related]
5. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574 [TBL] [Abstract][Full Text] [Related]
6. High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomas. Ramani P; Taylor S; Miller E; Sowa-Avugrah E; May MT J Histochem Cytochem; 2015 Jun; 63(6):397-407. PubMed ID: 25711230 [TBL] [Abstract][Full Text] [Related]
7. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas. Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832 [TBL] [Abstract][Full Text] [Related]
8. Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) antibody. Medani H; Elshiekh M; Naresh KN J Clin Pathol; 2021 Oct; 74(10):646-649. PubMed ID: 32873701 [TBL] [Abstract][Full Text] [Related]
9. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas. Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284 [TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma. Ladstein RG; Bachmann IM; Straume O; Akslen LA J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638 [TBL] [Abstract][Full Text] [Related]
11. LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers. Sundqvist B; Sihto H; von Willebrand M; Böhling T; Koljonen V Virchows Arch; 2021 Dec; 479(6):1197-1207. PubMed ID: 34331569 [TBL] [Abstract][Full Text] [Related]
12. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500 [TBL] [Abstract][Full Text] [Related]
13. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322 [TBL] [Abstract][Full Text] [Related]
14. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. Paulson KG; Iyer JG; Tegeder AR; Thibodeau R; Schelter J; Koba S; Schrama D; Simonson WT; Lemos BD; Byrd DR; Koelle DM; Galloway DA; Leonard JH; Madeleine MM; Argenyi ZB; Disis ML; Becker JC; Cleary MA; Nghiem P J Clin Oncol; 2011 Apr; 29(12):1539-46. PubMed ID: 21422430 [TBL] [Abstract][Full Text] [Related]
15. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies. Puripat N; Loharamtaweethong K Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302 [TBL] [Abstract][Full Text] [Related]
16. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility. Stetsenko GY; Malekirad J; Paulson KG; Iyer JG; Thibodeau RM; Nagase K; Schmidt M; Storer BE; Argenyi ZB; Nghiem P Am J Clin Pathol; 2013 Dec; 140(6):838-44. PubMed ID: 24225752 [TBL] [Abstract][Full Text] [Related]
17. Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast. Ginter PS; Shin SJ; Liu Y; Chen Z; D'Alfonso TM Hum Pathol; 2016 Mar; 49():90-8. PubMed ID: 26826415 [TBL] [Abstract][Full Text] [Related]
18. Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis. Iwasaki T; Matsushita M; Nonaka D; Nagata K; Kato M; Kuwamoto S; Murakami I; Hayashi K Hum Pathol; 2016 Feb; 48():1-8. PubMed ID: 26772392 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of phospho-histone H3 in prostate carcinoma. Nowak M; Svensson MA; Carlsson J; Vogel W; Kebschull M; Wernert N; Kristiansen G; Andrén O; Braun M; Perner S World J Urol; 2014 Jun; 32(3):703-7. PubMed ID: 23887713 [TBL] [Abstract][Full Text] [Related]
20. The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas. Aune G; Stunes AK; Tingulstad S; Salvesen O; Syversen U; Torp SH Int J Clin Exp Pathol; 2011 Jun; 4(5):444-53. PubMed ID: 21738816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]